Product Information
VANCOMYCIN HCL 250 MG CAPSULE is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $2.5976 per EA under NDC 23155085978. Its NADAC has been published 143 times since Jan 10, 2024.
FDA first approved this application on Apr 9, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155085978
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065490FDA Approved
4/9/2012
TE Code
AB
On Market Since
6/25/2023
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN HCL 250 MG CAPSULE has been published 143 times since Jan 10, 2024, and over the history we have for it it has risen 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5976 per EA |
|---|---|
| All-time high | $2.9252 (Aug 12, 2026) |
| All-time low | $1.4284 (Nov 20, 2024) |
| 52-week high | $2.9252 |
| 52-week low | $1.9613 |
| Median price | $2.1252 |
| Average price | $2.1156 |
| Largest weekly change | +41.0% (Aug 21, 2024) |
| Weeks tracked | 143 |
| Tracking since | Jan 10, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vancomycin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glycopeptide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANCOMYCIN HCL 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 250 MG CAPSULE, manufactured by Heritage Pharmaceuticals Inc., is $2.5976 per EA (NDC 23155085978), effective Sep 30, 2026.
How has the price of VANCOMYCIN HCL 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN HCL 250 MG CAPSULE has risen 23.7%. It has been tracked across 143 weekly CMS publications since Jan 10, 2024.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 250 MG CAPSULE?
Since Jan 10, 2024, the NADAC for VANCOMYCIN HCL 250 MG CAPSULE has ranged from a low of $1.4284 (Nov 20, 2024) to a high of $2.9252 (Aug 12, 2026), with a median of $2.1252 per EA.
Are there cheaper alternatives to VANCOMYCIN HCL 250 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VANCOMYCIN HCL 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VANCOMYCIN HCL 250 MG CAPSULE?
VANCOMYCIN HCL 250 MG CAPSULE (NDC 23155085978) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.